Study supports epoprostenol as anticoagulant in pediatric Aquadex therapy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. COHR
9. AMC
10. META

Go back to Study supports epoprostenol as anticoagulant in pediatric Aquadex therapy
(NASDAQ: NUWE) Delayed: 0.87 -0.03 (3.33%)
Previous Close $0.90    52 Week High $ 
Open $0.88    52 Week Low $ 
Day High $0.89    P/E N/A 
Day Low $0.84    EPS $ 
Volume 502,522